Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin

Diabetes

Volumn 59, Issue 4, 2010, Pages 1038-1045

  Rabbani, Naila ^a   Chittari, Madhu Varma ^a   Bodmer, Charles W ^b   Zehnder, Daniel ^a   Ceriello, Antonio ^a,c   Thornalley, Paul J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b O and G   (United Kingdom)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN B100; ARGININE DERIVATIVE; FRUCTOSYLLYSINE; GLICLAZIDE; GLIMEPIRIDE; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSINE DERIVATIVE; METFORMIN; METHIONINE SULFOXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIGESTION; DILUTION; DRUG EFFECT; ENZYME METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NITRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN GLYCOSYLATION; TANDEM MASS SPECTROMETRY; ULTRACENTRIFUGATION;

AGED; APOLIPOPROTEIN B-100; ARGININE; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; METFORMIN; MIDDLE AGED; REFERENCE VALUES;

EID: 77951183729     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-1455     Document Type: Article

References (31)

1. Grant PJ. The genetics of atherothrombotic disorders: a clinician's view. J Thromb Haemost 2003;1:1381-1390
2. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2004;46:733-749
3. Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003;31:1066-1069
4. Thornalley PJ. Quantitative screening of protein glycation, oxidation, and nitration adducts by LC-MS/MS: protein damage in diabetes, uremia, cirrhosis, and Alzheimer's disease. In Redox Proteomics. Dalle-Donne I, Scaloni A, Butterfield DA, Eds. Hoboken, NJ, Wiley, 2006, p. 681-728
5. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther 2008;22:215-224
6. Ohira M, Miyashita Y, Ebisuno M, Saiki A, Endo K, Koide N, Oyama T, Murano T, Watanabe H, Shirai K. Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 2007;78:34-41
7. Jialal I, Devaraj S. Remnant lipoproteins: measurement and clinical significance. Clin Chem 2002;48:217-219
8. Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999;48:198-202
9. Formoso G, De Filippis EA, Michetti N, Di Fulvio P, Pandolfi A, Bucciarelli T, Ciabattoni G, Nicolucci A, Davì G, Consoli A. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev 2008;24:231-237
10. Williamson KS, Hensley K, Floyd RA. Fluorometric and Colorimetric Assessment of Thiobarbituric Acid-Reactive Lipid Aldehydes in Biological Matrices. In Methods in Biological Oxidative Stress. Hensley K, Floyd RA, Eds. Totowa, NJ, Humana Press, 2003, p. 57-65
11. Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl) lysine-modified albumin. Biochem J 2002;364:1-14
12. Pietzsch J, Lattke P, Julius U. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time: in vivo insights from stable-isotope studies. Arterioscler Thromb Vasc Biol 2000;20:E63-E67
13. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003;375:581-592
14. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353
15. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci 1994;87:21-29
16. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 1982;31:283-291
17. Schleicher E, Deufel T, Wieland OH. Non-enzymatic glycation of human serum lipoproteins: elevated epsilon-lysine glycosylated low-density lipoprotein in diabetic patients. FEBS Letts 1981;129:1-4
18. Langer T, Levy RI, Strober W. Metabolism of low-density lipoprotein in familial type-H hyperlipoproteinemia. J Clin Invest 1972;51:1528-1536
19. Peters T. All About Albumin. New York, NY, Academic Press, 1996
20. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005;48:1590-1603
21. Banerjee D, Madhusoodanan UK, Sharanabasappa M, Ghosh S, Jacob J. Measurement of plasma hydroperoxide concentration by FOX-1 assay in conjunction with triphenylphosphine. Clinica Chimica Acta 2003;337:147-152
22. Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB, Benian GM, Lambeth JD. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 2001;154:879-891
23. Lambeth JD, Krause KH, Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 2008;30:339-363
24. Bhattacharjee S, Pennathur S, Byun J, Crowley J, Mueller D, Gischler J, Hotchkiss RS, Heinecke JW. NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys 2001;395:69-77
25. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997;272:3520-3526
26. Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab 2003;29:S95-S103
27. Battah S, Ahmed N, Thornalley PJ. Kinetics and mechanism of the reaction of metformin with methylglyoxal. Int Congr Ser 2002;1245:355-356
28. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005;28:2465-2471
29. Xue M, Thornalley PJ, Rabbani N. LDL glycated by methylglyoxal to physiological extent in vitro has increased binding of proteoglycan without impairment of LDL receptor binding. Diabetologia 2008;51:S299
30. Skålén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002;417:750-754
31. Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 2008;57:696-705